Christian W. Nolet's Insider Trades & SAST Disclosures

Christian W. Nolet's most recent trade in Revance Therapeutics Inc was a trade of 23,458 Stock Option (Right to buy) done . Disclosure was reported to the exchange on May 1, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Revance Therapeutics Inc
Christian W. Nolet Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2024 23,458 23,458 - - Stock Option (Right to buy)
Revance Therapeutics Inc
Christian W. Nolet Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2024 15,000 43,606 (0%) 0% 0 Common Stock
ArriVent BioPharma Inc.
Christian W. Nolet Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 17,884 17,884 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades